Analytical performance, reference values and decision limits. A need to differentiate between reference intervals and decision limits and to define analytical quality specifications

Abstract With the increasing use of decision limits (action limits, cut-off points) specified for a number of analytical components in diagnosis and for action in critical situations, formulated in national or international recommendations, the traditional interpretation of reference intervals has been uncertain, and sometimes the two concepts are being mixed up by incorporating risk calculations in the reference intervals. There is, therefore, a need to clarify the two concepts and to keep them definitely separated. Reference intervals are the 95% limits for the descriptions of the distributions of the values of analytical components measured on reference samples from reference individuals. Decision limits are based on guidelines from national and international expert groups defining specific concentrations of certain components as limits for decision about diagnosis or well-defined specific actions. Analytical quality specifications for reference intervals have been defined for bias since the 1990s, but in the recommendations specified in the clinical guidelines analytical quality specifications are only scarcely defined. The demands for negligible biases are, however, even more essential for decision limits, as the choice is no longer left to the clinician, but emerge directly from the concentration. Even a small bias will change the number of diseased individuals, so the demands for negligible biases are obvious. A view over the analytical quality as published gives a variable picture of bias for many components, but with many examples of considerable bias which must be critical – yet no specifications have been stipulated until now.

[1]  Aesha Drozdowski,et al.  Standards of medical care in diabetes. , 2004, Diabetes care.

[2]  P. H. Petersen,et al.  Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours. , 1992, European journal of cancer.

[3]  G. Sölétormos,et al.  Progression criteria for cancer antigen 15.3 and carcinoembryonic antigen in metastatic breast cancer compared by computer simulation of marker data. , 2000, Clinical chemistry.

[4]  Ivan Brandslund,et al.  Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. , 2011, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[5]  W. Guder,et al.  The Haemolytic, Icteric and Lipemic Sample Recommendations Regarding their Recognition and Prevention of Clinically Relevant Interferences. Recommendations of the Working Group on Preanalytical Variables of the German Society for Clinical Chemistry and the German Society for Laboratory Medicine , 2000 .

[6]  S. Skeie,et al.  Within-subject biological variation of glucose and HbA1c in healthy persons and in type 1 diabetes patients , 2011, Clinical chemistry and laboratory medicine.

[7]  W. Guder,et al.  Samples: From the Patient to the Laboratory , 2001 .

[8]  Advantages and disadvantages of serum cholesterol determination by the kinetic vs the end point method. , 2007, American journal of clinical pathology.

[9]  B. Doumas,et al.  Laboratory performance in neonatal bilirubin testing using commutable specimens: a progress report on a College of American Pathologists study. , 2009, Archives of pathology & laboratory medicine.

[10]  W. Guder,et al.  Preanalytical factors and their influence on analytical quality specifications. , 1999, Scandinavian journal of clinical and laboratory investigation.

[11]  Callum G. Fraser,et al.  Strategies to set global analytical quality specifications in laboratory medicine: 10 years on from the Stockholm consensus conference , 2010 .

[12]  A. Lyon,et al.  Use of Serial Patient Hemoglobin A1c Differences to Determine Long-Term Imprecision of Immunoassay and High-Performance Liquid Chromatography Analyzers , 2009, Journal of diabetes science and technology.

[13]  Cas Weykamp,et al.  IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. , 2004, Clinical chemistry.

[14]  L. Thienpont,et al.  Importance of sample-related effects for commutability testing according to the EP14 protocol. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[15]  M. Montagnana,et al.  Revaluation of biological variation of glycated hemoglobin (HbA(1c)) using an accurately designed protocol and an assay traceable to the IFCC reference system. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[16]  Callum G. Fraser,et al.  Biological Variation: From Principles to Practice , 2001 .

[17]  P. H. Petersen,et al.  Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria. , 2006, Clinical chemistry.

[18]  G. Klee Clinical interpretation of reference intervals and reference limits. A plea for assay harmonization , 2004, Clinical chemistry and laboratory medicine.

[19]  I. Brandslund,et al.  Serum HER-2 concentrations for monitoring women with breast cancer in a routine oncology setting , 2009, Clinical chemistry and laboratory medicine.

[20]  P. H. Petersen,et al.  Ways of assessing quality goals for diagnostic tests in clinical situations. , 1988, Archives of Pathology & Laboratory Medicine.

[21]  P. H. Petersen,et al.  Graphical interpretation of confidence curves in rankit plots , 2004, Clinical chemistry and laboratory medicine.

[22]  R. Paroni,et al.  Approved IFCC Reference Method for the Measurement of HbA1c in Human Blood , 2002, Clinical chemistry and laboratory medicine.

[23]  H. Vader,et al.  Do we measure bilirubin correctly anno 2005? , 2005, Clinical chemistry and laboratory medicine.

[24]  P. H. Petersen,et al.  Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies , 2004, Clinical chemistry and laboratory medicine.

[25]  Callum G Fraser,et al.  Objective criteria for partitioning Gaussian-distributed reference values into subgroups. , 2002, Clinical chemistry.

[26]  V. Patel,et al.  How to Diagnose Diabetes? Practicalities and Comments on the WHO Provisional Recommendation in Favour of HbA1c: , 2010 .

[27]  M. Panteghini,et al.  The Analytical Goals for Hemoglobin A1c Measurement in IFCC Units and National Glycohemoglobin Standardization , 2011 .

[28]  George G Klee,et al.  Establishment of outcome-related analytic performance goals. , 2010, Clinical chemistry.

[29]  P. H. Petersen,et al.  Reference intervals for plasma proteins: similarities and differences between adult Caucasian and Asian Indian males in Yorkshire, UK , 2004, Clinical chemistry and laboratory medicine.

[30]  H. E. Solberg Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits , 1987 .

[31]  M. Duffy,et al.  Serum tumor markers in breast cancer: are they of clinical value? , 2006, Clinical chemistry.

[32]  P. Wiggers,et al.  Screening for haemochromatosis: influence of analytical imprecision, diagnostic limit and prevalence on test validity. , 1991, Scandinavian journal of clinical and laboratory investigation.

[33]  M. Gellerstedt,et al.  Partitioning reference values for several subpopulations using cluster analysis , 2007, Clinical chemistry and laboratory medicine.

[34]  I. Brandslund,et al.  Plasma glucose reference interval in a low-risk population. 2. Impact of the new WHO and ADA recommendations on the diagnosis of diabetes mellitus. , 2001, Scandinavian journal of clinical and laboratory investigation.

[35]  C. Sturgeon,et al.  Why do immunoassays for tumour markers give differing results?--a view from the UK National External Quality Assessment Schemes. , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[36]  P. H. Petersen,et al.  Consequences Of Bias and Imprecision in Measurements of Glucose and Hba1c for the Diagnosis and Prognosis of Diabetes Mellitus , 2005, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[37]  Cautions in the adoption of common reference intervals. , 2008, Clinical chemistry.

[38]  L. Thienpont Accuracy in clinical chemistry – who will kiss Sleeping Beauty awake? , 2008, Clinical chemistry and laboratory medicine.

[39]  J. Connor,et al.  Clinical decision‐making as the basis for assessing agreement between measures of the International Normalized Ratio , 2009, Journal of thrombosis and haemostasis : JTH.

[40]  P. H. Petersen,et al.  Should we maintain the 95 percent reference intervals in the era of wellness testing? A concept paper , 2004, Clinical chemistry and laboratory medicine.

[41]  Sverre Sandberg,et al.  Discrepancies in international normalized ratio results between instruments: a model to split the variation into subcomponents. , 2010, Clinical chemistry.

[42]  J C Boyd,et al.  On dividing reference data into subgroups to produce separate reference ranges. , 1990, Clinical chemistry.

[43]  Andrew J Vickers,et al.  Cutpoints in clinical chemistry: time for fundamental reassessment. , 2009, Clinical chemistry.

[44]  Assessing quality in measurements of plasma proteins. The Nordic Protein Project and related projects. , 1994, Upsala journal of medical sciences.

[45]  L. Thienpont,et al.  Standardization activities in the field of thyroid function tests: a status report , 2010, Clinical chemistry and laboratory medicine.

[46]  Ferruccio Ceriotti,et al.  Reference intervals: the way forward , 2009, Annals of clinical biochemistry.

[47]  P. H. Petersen,et al.  Biological variation of International Normalized Ratio for prothrombin times, and consequences in monitoring oral anticoagulant therapy: computer simulation of serial measurements with goal-setting for analytical quality. , 1997, Clinical chemistry.

[48]  P. H. Petersen,et al.  Sampling time is important but may be overlooked in establishment and use of thyroid-stimulating hormone reference intervals. , 2007, Clinical chemistry.

[49]  C. Eby,et al.  Variability of ferritin measurements in chronic kidney disease; implications for iron management. , 2009, Kidney international.

[50]  C. Ricós,et al.  Procedure for studying commutability validated by biological variation. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[51]  A. Kallner,et al.  Can Age and Sex Related Reference Intervals Be Derived for Non-Healthy and Non-Diseased Individuals from Results of Measurements in Primary Health Care? , 2000, Clinical chemistry and laboratory medicine.

[52]  Linda M. Thienpont,et al.  Metrological traceability of calibration in the estimation and use of common medical decision-making criteria , 2004, Clinical chemistry and laboratory medicine.

[53]  C. Petitclerc Normality: the unreachable star? , 2004, Clinical chemistry and laboratory medicine.

[54]  Walter Hofmann,et al.  European Urinalysis Guidelines , 2000, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[55]  M. Plebani Quality specifications: self pleasure for clinical laboratories or added value for patient management? , 2007, Clinical chemistry and laboratory medicine.

[56]  E. K. Harris,et al.  Statistical criteria for separate reference intervals: race and gender groups in creatine kinase. , 1991, Clinical chemistry.

[57]  G S Cembrowski,et al.  Thoughts on quality-control systems: a laboratorian's perspective. , 1997, Clinical Chemistry.

[58]  I. Brandslund,et al.  ‘Likelihood-ratio’ and ‘odds’ applied to monitoring of patients as a supplement to ‘reference change value’ (RCV) , 2008, Clinical chemistry and laboratory medicine.

[59]  M Hørder,et al.  Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. , 1988, Scandinavian journal of clinical and laboratory investigation.

[60]  A. Griesmacher,et al.  Individual reference ranges of CA 15-3, MCA and CEA in recurrence of breast cancer. , 1995, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[61]  N. Milman Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. , 1996, International journal of hematology.

[62]  Anders Kallner,et al.  STRATEGIES TO SET GLOBAL ANALYTICAL QUALITY SPECIFICATION, IN LABORATORY MEDICINE , 1999 .

[63]  Jean-Claude Libeer,et al.  Proposals for Setting Generally Applicable Quality Goals Solely Based on Biology , 1997, Annals of clinical biochemistry.

[64]  G. Nordin Coefficient of variation for hemoglobin A1c results that are traceable to national glycohemoglobin standardization program must be distinguished from coefficient of variation for results traceable to International Federation of Clinical Chemistry and Laboratory Medicine. , 2011, Diabetes technology & therapeutics.

[65]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[66]  A. Killeen,et al.  Total long-term within-laboratory precision of cortisol, ferritin, thyroxine, free thyroxine, and thyroid-stimulating hormone assays based on a College of American Pathologists fresh frozen serum study: do available methods meet medical needs for precision? , 2005, Archives of pathology & laboratory medicine.

[67]  James O. Westgard,et al.  Cost-Effective Quality Control: Managing the Quality and Productivity of Analytical Processes , 1997 .

[68]  L. Lind,et al.  Reference Values for 27 Clinical Chemistry Tests in 70-Year-Old Males and Females , 2009, Gerontology.

[69]  A. Mosca,et al.  A Review of the Challenge in Measuring Hemoglobin A1c , 2009, Journal of diabetes science and technology.

[70]  G. Palomaki,et al.  Selecting clinically relevant populations for reference intervals , 2004, Clinical chemistry and laboratory medicine.

[71]  J C Boyd,et al.  Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. , 2001, Clinical chemistry.